Hahner Stefanie, Spinnler Christina, Fassnacht Martin, Burger-Stritt Stephanie, Lang Katharina, Milovanovic Danijela, Beuschlein Felix, Willenberg Holger S, Quinkler Marcus, Allolio Bruno
Endocrinology and Diabetes Unit (S.H., C.S., M.F., S.B.-S., K.L., D.M., B.A.), Department of Medicine I, University Hospital, and Comprehensive Heart Failure Center (S.H., M.F., B.A.), University of Wuerzburg, 97080 Wuerzburg, Germany; Department of Endocrine Research (F.B.), Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universität, 80539 Munich, Germany; Division for Specific Endocrinology (H.S.W.), Medical Faculty, University Duesseldorf, 40225 Duesseldorf, Germany; and Clinical Endocrinology Unit (M.Q.), Department of Medicine, Gastroenterology, Hepatology, and Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, 10117 Berlin, Germany.
J Clin Endocrinol Metab. 2015 Feb;100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24.
Adrenal crisis (AC) is a life-threatening complication of adrenal insufficiency (AI), which according to retrospective data represents a significant clinical complication. Here we aimed to prospectively assess incidence of AC and mortality associated with AC in patients with chronic AI.
A total of 423 patients with AI (primary AI, n = 221; secondary AI, n = 202) were prospectively followed up for 2 years. Baseline assessment included a general questionnaire and detailed written instructions on glucocorticoid dose adaptation during stress. Patients received follow-up questionnaires every 6 months and were contacted by phone in case of reported adrenal crisis.
A total of 423 data sets were available for baseline analysis, and 364 patients (86%) completed the whole study. Sixy-four AC in 767.5 patient-years were documented (8.3 crises per 100 patient-years). Precipitating causes were mainly gastrointestinal infection, fever, and emotional stress (20%, respectively) but also other stressful events (eg, major pain, surgery, strenuous physical activity, heat, pregnancy) or unexplained sudden onset of AC (7%) were documented. Patients with a previous AC were at higher risk of crisis (odds ratio 2.85, 95% confidence interval 1.5-5.5, P < .01). However, no further risk factors could be identified. Ten patients died during follow-up; in four cases death was associated with AC (0.5 AC related deaths per 100 patient-years).
Even in educated patients with chronic adrenal insufficiency, AC occurs in a substantial proportion of cases. Furthermore, we identified AC-associated mortality in approximately 6% of AC. Our findings further emphasize the need for improved management of AC in patients with chronic AI.
肾上腺危象(AC)是肾上腺功能不全(AI)的一种危及生命的并发症,根据回顾性数据,它是一种重要的临床并发症。我们旨在前瞻性评估慢性AI患者中AC的发生率以及与AC相关的死亡率。
对总共423例AI患者(原发性AI,n = 221;继发性AI,n = 202)进行了为期2年的前瞻性随访。基线评估包括一份一般问卷以及关于应激期间糖皮质激素剂量调整的详细书面说明。患者每6个月收到一次随访问卷,若报告发生肾上腺危象则通过电话联系。
共有423个数据集可用于基线分析,364例患者(86%)完成了整个研究。在767.5患者年中记录到64次AC(每100患者年8.3次危象)。诱发原因主要是胃肠道感染、发热和情绪应激(均为20%),但也记录到其他应激事件(如严重疼痛、手术、剧烈体育活动、高温、妊娠)或不明原因的AC突然发作(7%)。既往有AC的患者发生危象的风险更高(比值比2.85,95%置信区间1.5 - 5.5,P < 0.01)。然而,未发现其他危险因素。10例患者在随访期间死亡;4例死亡与AC相关(每100患者年0.5例AC相关死亡)。
即使在受过教育的慢性肾上腺功能不全患者中,相当一部分病例仍会发生AC。此外,我们发现约6%的AC与死亡相关。我们的研究结果进一步强调了改善慢性AI患者AC管理的必要性。